138 related articles for article (PubMed ID: 33832322)
21. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver.
Zheng XB; Chen XB; Xu LL; Zhang M; Feng L; Yi PS; Tang JW; Xu MQ
Cancer Sci; 2017 Mar; 108(3):338-346. PubMed ID: 28100026
[TBL] [Abstract][Full Text] [Related]
22. MiRNAs and LncRNAs: Dual Roles in TGF-β Signaling-Regulated Metastasis in Lung Cancer.
Lai XN; Li J; Tang LB; Chen WT; Zhang L; Xiong LX
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054031
[TBL] [Abstract][Full Text] [Related]
23. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
Sherman EJ; Mitchell DC; Garner AL
J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
[TBL] [Abstract][Full Text] [Related]
24. Role of miRNAs in human cancer metastasis: Implications for therapeutic intervention.
Jafri MA; Al-Qahtani MH; Shay JW
Semin Cancer Biol; 2017 Jun; 44():117-131. PubMed ID: 28188828
[TBL] [Abstract][Full Text] [Related]
25. miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
Chen Q; Hu H; Jiao D; Yan J; Xu W; Tang X; Chen J; Wang J
Oncol Rep; 2016 Aug; 36(2):909-17. PubMed ID: 27277197
[TBL] [Abstract][Full Text] [Related]
26. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
[No Abstract] [Full Text] [Related]
27. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway.
Sun CC; Li SJ; Yuan ZP; Li DJ
Aging (Albany NY); 2016 Oct; 8(10):2509-2524. PubMed ID: 27777383
[TBL] [Abstract][Full Text] [Related]
29. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
30. The biomarker features of miR-145-3p determined via meta-analysis validated by qRT-PCR in metastatic cancer cell lines.
Örs Kumoğlu G; Döşkaya M; Gulce Iz S
Gene; 2019 Aug; 710():341-353. PubMed ID: 31195093
[TBL] [Abstract][Full Text] [Related]
31. Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer.
Chen Y; Min L; Zhang X; Hu S; Wang B; Liu W; Wang R; Gu X; Shen W; Lv H; Zou J; Chen Y; Xu X; Chen L
Oncol Rep; 2013 Oct; 30(4):1832-40. PubMed ID: 23843100
[TBL] [Abstract][Full Text] [Related]
32. Novel insights into the role of microRNA in lung cancer resistance to treatment and targeted therapy.
Gong Z; Yang J; Li J; Yang L; Le Y; Wang S; Lin HK
Curr Cancer Drug Targets; 2014; 14(3):241-58. PubMed ID: 24605945
[TBL] [Abstract][Full Text] [Related]
33. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients.
Pujol JL; Boher JM; Grenier J; Quantin X
Lung Cancer; 2001; 31(2-3):221-31. PubMed ID: 11165401
[TBL] [Abstract][Full Text] [Related]
34. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A
Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-mediated cancer metastasis regulation via heterotypic signals in the microenvironment.
Ma H; Liang C; Wang G; Jia S; Zhao Q; Xiang Z; Li Y; Cho WC; Pestell RG; Liang L; Yu Z
Curr Pharm Biotechnol; 2014; 15(5):455-8. PubMed ID: 24846069
[TBL] [Abstract][Full Text] [Related]
36. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
37. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
[TBL] [Abstract][Full Text] [Related]
38. A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.
Pecqueux M; Liebetrau I; Werft W; Dienemann H; Muley T; Pfannschmidt J; Müssle B; Rahbari N; Schölch S; Büchler MW; Weitz J; Reissfelder C; Kahlert C
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775664
[TBL] [Abstract][Full Text] [Related]
39. CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway.
Tang F; Tang S; Guo X; Yang C; Jia K
Mol Med Rep; 2017 Nov; 16(5):6708-6714. PubMed ID: 28901509
[TBL] [Abstract][Full Text] [Related]
40. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
